The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis

Jon Mabley, F.G. Soriano, P. Pacher, G. Hasko, A. Marton, R. Wallace, A.L. Salzman, C. Szabo

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulphate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice. IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day. Evaluation of colon damage and inflammation was determined grossly (body weight, rectal bleeding) and biochemically (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines). There was significantly increased inflammatory cell infiltration into the colon associated with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulphate-induced colitis and 10-week-old interleukin-10−/− mice. IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels. Thus activation of the adenosine A3 receptor is effective in protecting against colitis.
Original languageEnglish
Pages (from-to)323-329
Number of pages7
JournalEuropean Journal of Pharmacology
Volume466
Issue number3
Publication statusPublished - Apr 2003

Fingerprint

Adenosine A3 Receptor Agonists
Colitis
Adenosine
Colon
Chemokines
Dextran Sulfate
Cytokines
Interleukin-10
Adenosine A3 Receptors
Malondialdehyde
Peroxidase
Free Radicals
Body Weight
Hemorrhage
Inflammation

Keywords

  • Colitis
  • Adenosine
  • Cytokine
  • Chemokine

Cite this

Mabley, Jon ; Soriano, F.G. ; Pacher, P. ; Hasko, G. ; Marton, A. ; Wallace, R. ; Salzman, A.L. ; Szabo, C. / The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis. In: European Journal of Pharmacology. 2003 ; Vol. 466, No. 3. pp. 323-329.
@article{dd8dcca09d7540258af61a6c2cbeff05,
title = "The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis",
abstract = "This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulphate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice. IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day. Evaluation of colon damage and inflammation was determined grossly (body weight, rectal bleeding) and biochemically (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines). There was significantly increased inflammatory cell infiltration into the colon associated with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulphate-induced colitis and 10-week-old interleukin-10−/− mice. IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels. Thus activation of the adenosine A3 receptor is effective in protecting against colitis.",
keywords = "Colitis, Adenosine, Cytokine, Chemokine",
author = "Jon Mabley and F.G. Soriano and P. Pacher and G. Hasko and A. Marton and R. Wallace and A.L. Salzman and C. Szabo",
year = "2003",
month = "4",
language = "English",
volume = "466",
pages = "323--329",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
number = "3",

}

Mabley, J, Soriano, FG, Pacher, P, Hasko, G, Marton, A, Wallace, R, Salzman, AL & Szabo, C 2003, 'The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis', European Journal of Pharmacology, vol. 466, no. 3, pp. 323-329.

The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis. / Mabley, Jon; Soriano, F.G.; Pacher, P.; Hasko, G.; Marton, A.; Wallace, R.; Salzman, A.L.; Szabo, C.

In: European Journal of Pharmacology, Vol. 466, No. 3, 04.2003, p. 323-329.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis

AU - Mabley, Jon

AU - Soriano, F.G.

AU - Pacher, P.

AU - Hasko, G.

AU - Marton, A.

AU - Wallace, R.

AU - Salzman, A.L.

AU - Szabo, C.

PY - 2003/4

Y1 - 2003/4

N2 - This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulphate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice. IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day. Evaluation of colon damage and inflammation was determined grossly (body weight, rectal bleeding) and biochemically (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines). There was significantly increased inflammatory cell infiltration into the colon associated with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulphate-induced colitis and 10-week-old interleukin-10−/− mice. IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels. Thus activation of the adenosine A3 receptor is effective in protecting against colitis.

AB - This study evaluated the effects of the adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide (IB-MECA), in two murine models of colitis, the dextran sodium sulphate-induced colitis and the spontaneous colitis found in interleukin-10 gene deficient mice. IB-MECA was given orally twice a day at a dose of either 1 or 3 mg/kg/day. Evaluation of colon damage and inflammation was determined grossly (body weight, rectal bleeding) and biochemically (colon levels of myeloperoxidase, malondialdehyde, chemokines and cytokines). There was significantly increased inflammatory cell infiltration into the colon associated with an increase in colon levels of cytokines and chemokines; with subsequent free radical related damage in both dextran sodium sulphate-induced colitis and 10-week-old interleukin-10−/− mice. IB-MECA protected in both models against the colitis induced inflammatory cell infiltration and damage and attenuated the increases in colon inflammatory cytokine and chemokine levels. Thus activation of the adenosine A3 receptor is effective in protecting against colitis.

KW - Colitis

KW - Adenosine

KW - Cytokine

KW - Chemokine

M3 - Article

VL - 466

SP - 323

EP - 329

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -